Forward Citations = 2

Loading Chart...

6 inventors (with patents filed for the assignee):

Ramila Philip (13 out of 20 patents)

Thomas Rademacher (2 out of 2 patents)

Christopher Upton (1 out of 2 patents)

4. Richard David Perrins (1 out of 1 patent)

5. Xiaofang Huang (1 out of 1 patent)

6. Laurens Rademacher (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 12409215 - Vaccine compositions (2025-09-09),

2. 12178867 - MHC class i associated peptides for prevention and treatment of multiple flavi virus (2024-12-31),

3. 12156909 - Reverse peptide vaccine (2024-12-03),

4. 11931407 - MHC class I associated peptides for prevention and treatment of zika virus (2024-03-19),

5. 11690904 - MHC class I associated peptides for prevention and treatment of multiple flavi virus (2023-07-04),

6. 11426457 - MHC class I associated peptides for prevention and treatment of zika virus (2022-08-30),

7. 11344614 - Pharmaceutical compositions comprising dengue virus-specific multiple HLA-binding T cell epitopes (2022-05-31),

8. 11273216 - Universal influenza vaccine compositions (2022-03-15),

9. 11191828 - MHC class I associated hepatitis B peptides (2021-12-07),

10. 10556929 - Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of dengue virus infection (2020-02-11),

11. 10155036 - MHC class I associated peptides for prevention and treatment of hepatitis B virus infection (2018-12-18),

12. 10144766 - Cytotoxic T Lymphocyte inducing immunogens for prevention treatment and diagnosis of dengue virus infection (2018-12-04),

13. 10117922 - Dengue virus specific multiple HLA binding T cell epitopes for the use of universal vaccine development (2018-11-06),

Company Overview

Emergex Vaccines Holding Limited is a biotechnology company based in Oxfordshire, specializing in the development of innovative vaccines. The organization focuses on harnessing advanced technologies to create immune responses against infectious diseases, particularly those that pose significant global health threats. By leveraging cutting-edge research in immunology and vaccine design, Emergex aims to provide effective solutions that enhance public health and address unmet medical needs in various regions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#11 in Oxfordshire

#1,365 in United Kingdom

#45,081 in the World

Oxfordshire, United Kingdom

Emergex Vaccines Holding Limited

Forward Citations = 2

6 inventors:

Ramila Philip (13 out of 20 patents)

Thomas Rademacher (2 out of 2 patents)

Christopher Upton (1 out of 2 patents)

4. Richard David Perrins (1 out of 1 patent)

5. Xiaofang Huang (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Emergex Vaccines Holding Limited. Retrieved from https://idiyas.com/company/emergex-vaccines-holding

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]